MCID: MNN009
MIFTS: 50

Meningoencephalitis

Categories: Neuronal diseases

Aliases & Classifications for Meningoencephalitis

MalaCards integrated aliases for Meningoencephalitis:

Name: Meningoencephalitis 12 55 44 15 17 72

Classifications:



External Ids:

Disease Ontology 12 DOID:10554
MeSH 44 D008590
NCIt 50 C34813
SNOMED-CT 68 7125002
ICD10 33 A69.22 G04
UMLS 72 C0025309

Summaries for Meningoencephalitis

Disease Ontology : 12 A central nervous system disease that involves encephalitis which occurs along with meningitis.

MalaCards based summary : Meningoencephalitis is related to parotitis and toxoplasmosis. An important gene associated with Meningoencephalitis is CD40LG (CD40 Ligand), and among its related pathways/superpathways are Innate Immune System and PAK Pathway. The drugs Immunologic Factors and Antibodies have been mentioned in the context of this disorder. Affiliated tissues include brain, t cells and testes, and related phenotypes are homeostasis/metabolism and cellular

Wikipedia : 75 Meningoencephalitis (/mEaEOnEaAnEOsE>fETE^laEatEas, -EOnEandE'oES-, -ETn-, -EOkE>-/; from Greek... more...

Related Diseases for Meningoencephalitis

Diseases related to Meningoencephalitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 701)
# Related Disease Score Top Affiliating Genes
1 parotitis 31.2 CD79A ALB
2 toxoplasmosis 31.2 IL6 CD79A CD40LG
3 acquired immunodeficiency syndrome 31.1 IL6 B2M ALB
4 otitis media 30.9 IL6 CD79A ALB
5 peritonitis 30.7 IL6 B2M ALB
6 syphilis 30.6 CD79A CD40LG B2M
7 chronic graft versus host disease 30.6 CD79A ALB
8 guillain-barre syndrome 30.5 MBP CD79A ALB
9 secondary syphilis 30.3 CD79A CD40LG
10 trypanosomiasis 30.0 IL6 CCL5 ALB
11 viral encephalitis 29.9 MBP IL6 CCL5
12 pneumonia 29.9 IL6 CD40LG CCL5
13 traumatic brain injury 29.9 MBP IL6 BDNF
14 cytomegalovirus infection 29.8 IL6 CCL5 B2M
15 myeloma, multiple 29.8 IL6 CD79A B2M ALB
16 mastitis 29.6 IL6 CCL5 ALB
17 human immunodeficiency virus type 1 29.4 IL6 GDNF CCL5 B2M
18 peripheral nervous system disease 29.3 NGF MBP IL6 ALB
19 proteasome-associated autoinflammatory syndrome 1 29.3 IL6 CCL5 ALB
20 demyelinating disease 29.1 MBP CD40LG CCL5
21 relapsing-remitting multiple sclerosis 28.8 MBP CCL5 BDNF
22 multiple sclerosis 28.8 MBP IL6 CCL5 BDNF
23 systemic lupus erythematosus 28.5 MECP2 IL6 CD79A CD40LG CCL5 C5
24 central nervous system disease 28.5 NGF MBP IL6 GDNF BDNF APP
25 nervous system disease 28.1 NGF MBP IL6 GDNF BDNF APP
26 primary amebic meningoencephalitis 12.8
27 lymphocytic choriomeningitis 12.0
28 tick-borne encephalitis 11.5
29 trichinosis 11.5
30 pulmonary alveolar microlithiasis 11.2
31 parenchymatous neurosyphilis 11.2
32 tick infestation 11.2
33 amoebiasis due to free-living amoebae 11.2
34 listeriosis 10.9
35 encephalitis 10.8
36 c1q nephropathy 10.7 CD79A CD40LG
37 tinea profunda 10.7 CARD9 ALB
38 immunoglobulin g deficiency 10.7 CD79A CD40LG
39 cryofibrinogenemia 10.7 CD79A CD40LG
40 meningitis 10.7
41 fournier gangrene 10.7 CD40LG ALB
42 heparin-induced thrombocytopenia 10.7 CD79A CD40LG
43 immunodeficiency 43 10.6 B2M ALB
44 congenital syphilis 10.6 CD79A CD40LG
45 sporotrichosis 10.6 CD79A CD40LG
46 root caries 10.6 CD79A ALB
47 immunoglobulin a deficiency 1 10.6 CD79A CD40LG
48 mumps 10.6
49 extramedullary plasmacytoma 10.6 IL6 B2M
50 glomerulonephritis 10.6 CD79A CD40LG ALB

Graphical network of the top 20 diseases related to Meningoencephalitis:



Diseases related to Meningoencephalitis

Symptoms & Phenotypes for Meningoencephalitis

MGI Mouse Phenotypes related to Meningoencephalitis:

46 (show all 15)
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.3 ALB APP B2M BDNF C5 CARD9
2 cellular MP:0005384 10.26 ALB APP B2M BDNF CD40LG CD79A
3 behavior/neurological MP:0005386 10.25 APP BDNF C5 CHKB CREBBP GDNF
4 immune system MP:0005387 10.21 APP B2M C5 CARD9 CCL5 CD40LG
5 growth/size/body region MP:0005378 10.19 APP B2M BDNF C5 CREBBP GDNF
6 hematopoietic system MP:0005397 10.18 APP B2M CARD9 CCL5 CD40LG CD79A
7 cardiovascular system MP:0005385 10.14 APP B2M CD40LG CREBBP GDNF IL6
8 endocrine/exocrine gland MP:0005379 10.11 ALB B2M BDNF CD40LG CREBBP GDNF
9 mortality/aging MP:0010768 10.1 ALB APP B2M BDNF C5 CD40LG
10 integument MP:0010771 10.01 APP B2M BDNF CD40LG CREBBP IL6
11 nervous system MP:0003631 9.97 APP B2M BDNF C5 CD40LG CD79A
12 liver/biliary system MP:0005370 9.91 ALB B2M C5 CD79A CREBBP IL6
13 muscle MP:0005369 9.8 ALB APP CHKB CREBBP GDNF IL6
14 normal MP:0002873 9.61 ALB APP BDNF C5 CD79A CREBBP
15 reproductive system MP:0005389 9.23 APP B2M BDNF CD40LG GDNF IL6

Drugs & Therapeutics for Meningoencephalitis

Drugs for Meningoencephalitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 66)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Immunologic Factors Phase 3
2 Antibodies Phase 3
3 Immunoglobulins Phase 3
4 gamma-Globulins Phase 3
5 Immunoglobulins, Intravenous Phase 3
6 Rho(D) Immune Globulin Phase 3
7
Aluminum hydroxide Approved, Investigational Phase 2 21645-51-2
8
Aluminum sulfate Approved Phase 2 10043-01-3
9
Valganciclovir Approved, Investigational Phase 2 175865-60-8 64147
10
Fluconazole Approved, Investigational Phase 2 86386-73-4 3365
11
Miconazole Approved, Investigational, Vet_approved Phase 2 22916-47-8 4189
12
Tamoxifen Approved Phase 2 10540-29-1 2733526
13
Amphotericin B Approved, Investigational Phase 2 1397-89-3 14956 5280965
14 Pleconaril Investigational Phase 2 153168-05-9
15 Gastrointestinal Agents Phase 2
16 Antiviral Agents Phase 2
17 Vaccines Phase 2
18 Antacids Phase 2
19 Adjuvants, Immunologic Phase 2
20 Anti-Ulcer Agents Phase 2
21 Anti-Bacterial Agents Phase 2
22 Antiparasitic Agents Phase 2
23 Antiprotozoal Agents Phase 2
24 Anti-Infective Agents Phase 2
25 14-alpha Demethylase Inhibitors Phase 2
26 Hormones Phase 2
27 Cytochrome P-450 CYP2C9 Inhibitors Phase 2
28 Cytochrome P-450 Enzyme Inhibitors Phase 2
29 Antifungal Agents Phase 2
30 Steroid Synthesis Inhibitors Phase 2
31 Cytochrome P-450 CYP2C19 Inhibitors Phase 2
32 Hormone Antagonists Phase 2
33 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 2
34 Selective Estrogen Receptor Modulators Phase 2
35 Estrogens Phase 2
36 Cytochrome P-450 CYP3A Inhibitors Phase 2
37 Liposomal amphotericin B Phase 2
38 Antineoplastic Agents, Hormonal Phase 2
39 Estrogen Receptor Modulators Phase 2
40 Estrogen Receptor Antagonists Phase 2
41 Estrogen Antagonists Phase 2
42 Bone Density Conservation Agents Phase 2
43
Nevirapine Approved 129618-40-2 4463
44
Lamivudine Approved, Investigational 134678-17-4 60825
45
Stavudine Approved, Investigational 3056-17-5 18283
46
Dopamine Approved 51-61-6, 62-31-7 681
47
Acyclovir Approved 59277-89-3 2022
48
Ceftriaxone Approved 73384-59-5 5479530 5361919
49
Doxycycline Approved, Investigational, Vet_approved 564-25-0 54671203
50 Cytochrome P-450 CYP3A Inducers

Interventional clinical trials:

(show all 25)
# Name Status NCT ID Phase Drugs
1 A Phase III Multi-centre Randomised, Double Blind, Placebo Controlled Trial to Assess the Role of Intravenous Immunoglobulin in the Management of Children With Encephalitis Active, not recruiting NCT02308982 Phase 3 Immunoglobulins, Intravenous (Privigen);Placebo
2 A Phase II Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and Infants Completed NCT01399853 Phase 2
3 A Booster Dose of Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children Completed NCT01734408 Phase 2
4 Double Blinded Placebo Controlled Study to Assess Clinical and Antiviral Activity of Valganciclovir (VAL) in Solid Organ Transplant Donors to Reduce Viral Transmission From Donor to Recipient Completed NCT01329185 Phase 2 Valganciclovir;Placebo
5 A Double-Blind, Placebo-Controlled, Virologic Efficacy Trial of Pleconaril in the Treatment of Neonates With Enteroviral Sepsis Syndrome Completed NCT00031512 Phase 2 Placebo;Pleconaril (VP63843)
6 A Randomized Double Blind Placebo Controlled Trial to Assess the Safety and Efficacy of Intravenous Immunoglobulin (IVIG) in Children With Japanese Encephalitis in Nepal Completed NCT01856205 Phase 2 Intravenous immunoglobulin [ImmunoRel™ (batch 20081217)]
7 A Randomized Trial of Tamoxifen Combined With Amphotericin B and Fluconazole for Cryptococcal Meningitis Active, not recruiting NCT03112031 Phase 2 Tamoxifen;Amphotericin B;Fluconazole
8 Pharmacokinetic Study of AVI-4020 in Cerebral Spinal Fluid Among Healthy Adult Males Following Intravenous Administration Completed NCT00387283 Phase 1 AVI-4020 Injection
9 A Phase Ib Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and Infants Completed NCT01313715 Phase 1
10 A Phase Ia Clinical Trial for Inactivated Vaccine(Vero Cell) Against EV71 in Chinese Healthy Young Adults and Children Completed NCT01267903 Phase 1
11 An Exploratory Study of the Safety, Tolerability, Pharmacokinetics and Potential Effectiveness of AVI-4020 Injection in Patients Presenting With Presumptive Acute Neuroinvasive West Nile Virus (WNV) Disease Terminated NCT00091845 Phase 1 AVI-4020 Injection
12 Etiology of Orphan Community-based Meningitis and Meningo-encephalitis. Unknown status NCT02868593
13 sCD163 & CD19 as Candidate Biomarkers in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - A Study of sCD163 in the Cerebrospinal Fluid Unknown status NCT02271724
14 sCD163 as a Potential Biomarker in Guillain- Barré Syndrome Unknown status NCT02582853
15 Cerebrospinal Fluid Polymerase Chain Reaction Arrays for Central Nervous System Neurotropic Viral Infection and Mycobacterium Infection Study Completed NCT00807378
16 Randomized Control Trial of Early vs Delayed ART in the Treatment of Cryptococcal Meningitis. Completed NCT00830856 Fluconazole;Fixed dose - Stavudine, lamivudine and Nevirapine;Fixed dose - Stavudine, Lamivudine, Nevirapine
17 Inflammation in Amyotrophic Lateral Sclerosis - a Study of Soluble Cluster of Differentiation 163 in the Cerebrospinal Fluid Completed NCT02325375
18 Prospective Study of the Etiology, Pathogenesis, Clinical Picture and Outcome of Aseptic Meningitis in Slovenia Recruiting NCT02328469 symptomatic therapy;Ceftriaxone or Doxycycline;Acyclovir
19 Application of Next Generation Sequencing Technique in Pediatric Bacterial Meningitis Recruiting NCT03953638
20 Research for Angiostrongylus Cantonensis and Costaricensis in French West Indies and French Guiana: a Clinical and Environmental Study Recruiting NCT03378882
21 Fever After Tick Bite (FATB) Study; Determining the Etiology of Tick-Borne Human Infections in Northern Europe Recruiting NCT03932448
22 The Identification and Quantification of HIV CNS Latency Biomarkers Recruiting NCT02989285
23 Integrating the Diagnosis and Management of HIV-associated Central Nervous System (CNS) Infections Into Routine Health Services in Low and Middle Income Countries (LMICs) Recruiting NCT03226379
24 Prevalence of Pathogens in Cerebrospinal Fluid Obtained From Emergency Department Patients Active, not recruiting NCT02207647
25 Implementation and Evaluation of a Screening Strategy to Reduce Morbidity and Mortality Due to Cryptoccocal Meningo-encephalitis in ART Naive AIDS Patients With <100 CD4 Count at the Day Hospital of the Yaounde Central Hospital, Cameroon Active, not recruiting NCT02624453 Fluconazole;Antiretroviral therapy

Search NIH Clinical Center for Meningoencephalitis

Cochrane evidence based reviews: meningoencephalitis

Genetic Tests for Meningoencephalitis

Anatomical Context for Meningoencephalitis

MalaCards organs/tissues related to Meningoencephalitis:

41
Brain, T Cells, Testes, Endothelial, Bone, Kidney, Neutrophil

Publications for Meningoencephalitis

Articles related to Meningoencephalitis:

(show top 50) (show all 6790)
# Title Authors PMID Year
1
HLA-DR alleles in amyloid beta-peptide autoimmunity: a highly immunogenic role for the DRB1*1501 allele. 9 38
19675171 2009
2
Abeta-induced meningoencephalitis is IFN-gamma-dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer's disease. 9 38
16549802 2006
3
Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease. 9 38
14997933 2004
4
Clinical and neuroinflammatory responses to meningoencephalitis in substance P receptor knockout mice. 9 38
12805119 2003
5
No evidence for elevated numbers of mononuclear cells expressing MCP-1 and RANTES mRNA in blood and CSF in multiple sclerosis. 9 38
9846826 1998
6
A substance P antagonist, RP-67,580, ameliorates a mouse meningoencephalitic response to Trypanosoma brucei brucei. 9 38
9108123 1997
7
Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis. 9 38
1690527 1990
8
Basic principles of the virulence of Cryptococcus. 38
31119976 2019
9
Fantastic yeasts and where to find them: the discovery of a predominantly clonal Cryptococcus deneoformans population in Saudi Arabian soils. 38
31344232 2019
10
Lesions and Distribution of Viral Antigen in the Brain of Hamsters Infected With Equine Herpesvirus (EHV)-9, EHV-1 Strain Ab4p, and Zebra-Borne EHV-1. 38
30686182 2019
11
Cerebral Trypanosomiasis in an Immunocompromised Patient: Case Report and Review of the Literature. 38
31176839 2019
12
Hospital-based zoonotic disease surveillance in Bangladesh: design, field data and difficulties. 38
31401956 2019
13
Intranasal Inoculation of Cryptococcus neoformans in Mice Produces Nasal Infection with Rapid Brain Dissemination. 38
31391283 2019
14
Neurologic Complications of Infective Endocarditis: A Joint Model for a Septic Thromboembolism and Inflammatory Small Vessel Disease. 38
31149963 2019
15
Oleic Acid Coated Silver Nanoparticles Showed Better in Vitro Amoebicidal Effects against Naegleria fowleri than Amphotericin B. 38
31347828 2019
16
In Vitro Activity of Statins against Naegleria fowleri. 38
31398829 2019
17
Application of Recombinant Angiostrongylus cantonensis Galectin-2 Protein for Serodiagnosis of Human Angiostrongyliasis by Immunoblotting. 38
31392957 2019
18
A Case Report of Slug Ingestion Causing Eosinophilic Meningitis, Papilledema, and Pronounced Motor Weakness in a US Marine. 38
31436288 2019
19
Meningoencephalitis due to spotted fever rickettsioses, including Rocky Mountain spotted fever. 38
31412360 2019
20
"886-84-like" tick-borne encephalitis virus strains: Intraspecific status elucidated by comparative genomics. 38
31253516 2019
21
Cryptococcal Meningoencephalitis Presenting as a Psychiatric Emergency. 38
31014972 2019
22
A case report of Coccidioides posadasii meningoencephalitis in an immunocompetent host. 38
31420023 2019
23
The eye is the window to the diagnosis: tuberculous meningoencephalitis with choroidal tubercle. 38
31427384 2019
24
Human Parechovirus Meningoencephalitis: Neuroimaging in the Era of Polymerase Chain Reaction-Based Testing. 38
31272964 2019
25
Serologic evidence of widespread Toscana virus infection in Bulgaria. 38
31401037 2019
26
Anatomical hemispherectomy revisited-outcome, blood loss, hydrocephalus, and absence of chronic hemosiderosis. 38
31243582 2019
27
Associations between the presence of specific antibodies to the West Nile Virus infection and candidate genes in Romanian horses from the Danube delta. 38
31175514 2019
28
Meningoencephalitis Caused by a Campylobacter fetus in a Patient with Chronic Alcoholism. 38
30918169 2019
29
First report of an outbreak of cerebral coenurosis in Dhofari goats in Oman. 38
31390436 2019
30
Host Invasion by Pathogenic Amoebae: Epithelial Disruption by Parasite Proteins. 38
31416298 2019
31
Chronic myelitis associated with zoster sine herpete: A case report. 38
31393366 2019
32
Cryptococcus neoformans infection in Human Immunodeficiency Virus (HIV)-infected and HIV-uninfected patients at an inner-city tertiary care hospital in the Bronx. 38
31342058 2019
33
Molecular, serological, pathological, immunohistochemical and microbiological investigation of Brucella spp. in marine mammals of Brazil reveals new cetacean hosts. 38
30980699 2019
34
Cerebrospinal fluid light and heavy neurofilament level increased in anti-N-methyl-d-aspartate receptor encephalitis. 38
31313506 2019
35
Pioglitazone as an adjuvant of amphotericin B for the treatment of cryptococcosis. 38
31279153 2019
36
Disseminated melanized fungal infection due to Cladosporium halotolerans in a dog coinfected with canine adenovirus-1 and canine parvovirus-2. 38
30997656 2019
37
Severe Epididymo-Orchitis and Encephalitis Complicating Anti-PD-1 Therapy. 38
30936376 2019
38
Short communication: In vitro and in vivo probiotic potential of Lactobacillus plantarum B7 and Lactobacillus rhamnosus D1 isolated from Minas artisanal cheese. 38
31128873 2019
39
Biotic concerns in generating molecular diagnosis matrixes for 4 avian viruses with emphasis on Marek's disease virus. 38
31351169 2019
40
Central nervous system diseases of cattle in Georgia, 2001-2017. 38
31179896 2019
41
Effective antiviral medicinal plants and biological compounds against central nervous system infections: A mechanistic review. 38
31309894 2019
42
Audiologic and Otologic Complications of Cryptococcal Meningoencephalitis in Non-HIV Previously Healthy Patients. 38
31157723 2019
43
Meningitis and epididymitis caused by Toscana virus infection imported to Switzerland diagnosed by metagenomic sequencing: a case report. 38
31286879 2019
44
Antiparasitic Activity of Auranofin against Pathogenic Naegleria fowleri. 38
30520183 2019
45
Clinical characteristic of 15 cases of cryptococcal meningitis treated with Ommaya reservoir. 38
31321616 2019
46
Meningoencephalitis caused by Lactobacillus plantarum - case report. 38
29813007 2019
47
Invasive meningoencephalitis as the first manifestation of hepatitis A. 38
31319008 2019
48
The role of CNS macrophages in streptococcal meningoencephalitis. 38
30762892 2019
49
A Large Cohort of Neurocysticercosis in Shandong Province, Eastern China, 1997-2015. 38
31314709 2019
50
Reduced phagocytosis and killing of Cryptococcus neoformans biofilm-derived cells by J774.16 macrophages is associated with fungal capsular production and surface modification. 38
31356873 2019

Variations for Meningoencephalitis

Expression for Meningoencephalitis

Search GEO for disease gene expression data for Meningoencephalitis.

Pathways for Meningoencephalitis

Pathways related to Meningoencephalitis according to GeneCards Suite gene sharing:

(show all 17)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.82 IL6 GDNF CREBBP CD79A CD40LG CCL5
2
Show member pathways
13.09 NGF IL6 CREBBP CD40LG CCL5 BDNF
3
Show member pathways
12.86 NGF IL6 CREBBP CD79A BDNF
4
Show member pathways
12.67 IL6 GDNF CD40LG C5 B2M
5 12.39 NGF MECP2 MBP APP
6
Show member pathways
12.39 NGF IL6 CREBBP CD40LG BDNF
7 12.07 CD79A CD40LG CCL5 CARD9 B2M
8
Show member pathways
11.73 NGF IL6 CREBBP CCL5 BDNF
9 11.57 NGF GDNF BDNF
10 11.56 NGF MECP2 IL6 CREBBP BDNF
11 11.5 IL6 CCL5 BDNF
12
Show member pathways
11.45 NGF BDNF APP
13 11.41 MECP2 IL6 CCL5
14 11.37 MECP2 MBP BDNF
15 11.1 MBP IL6 GDNF C5 BDNF
16 10.98 IL6 CCL5 C5
17 10.81 NGF IL6 CD40LG CCL5 BDNF

GO Terms for Meningoencephalitis

Cellular components related to Meningoencephalitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.65 NGF IL6 GDNF CD40LG CCL5 C5
2 endoplasmic reticulum lumen GO:0005788 9.46 IL6 B2M APP ALB
3 extracellular space GO:0005615 9.32 NGF MECP2 IL6 CD40LG CCL5 C5

Biological processes related to Meningoencephalitis according to GeneCards Suite gene sharing:

(show all 17)
# Name GO ID Score Top Affiliating Genes
1 negative regulation of apoptotic process GO:0043066 9.91 NGF IL6 GDNF CD40LG ALB
2 inflammatory response GO:0006954 9.87 IL6 CD40LG CCL5 C5
3 immune response GO:0006955 9.85 MBP IL6 CD40LG CCL5 B2M
4 memory GO:0007613 9.67 NGF MECP2 BDNF
5 cellular protein metabolic process GO:0044267 9.67 IL6 B2M APP ALB
6 neurotrophin TRK receptor signaling pathway GO:0048011 9.56 NGF BDNF
7 positive regulation of T cell migration GO:2000406 9.55 CCL5 APP
8 nerve development GO:0021675 9.54 NGF BDNF
9 nerve growth factor signaling pathway GO:0038180 9.52 NGF BDNF
10 positive regulation of T cell proliferation GO:0042102 9.5 IL6 CD40LG CCL5
11 positive regulation of collateral sprouting GO:0048672 9.48 NGF BDNF
12 negative regulation of neuron apoptotic process GO:0043524 9.46 NGF MECP2 GDNF BDNF
13 response to peptidoglycan GO:0032494 9.43 IL6 CARD9
14 adult locomotory behavior GO:0008344 9.43 MECP2 GDNF APP
15 positive regulation of receptor binding GO:1900122 9.4 BDNF B2M
16 neuron projection development GO:0031175 9.26 MECP2 IL6 GDNF APP
17 peripheral nervous system development GO:0007422 8.8 NGF GDNF BDNF

Molecular functions related to Meningoencephalitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protein binding GO:0005515 9.8 NGF MECP2 MBP IL6 GDNF CREBBP
2 growth factor activity GO:0008083 8.92 NGF IL6 GDNF BDNF

Sources for Meningoencephalitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....